Insights, how-to guides, and market updates from the ipomarket.in research team.
Surgiwear — a Uttar Pradesh-based domestic manufacturer of orthopaedic implants, hydrocephalus shunts and sterile surgical drapes — received SEBI approval on May 4, 2026 for a ~₹740 crore IPO comprising a ₹370 crore fresh issue and a ₹370 crore OFS by promoter Ghanshyam Das Agarwal. With India's medical-devices market on a structural growth trajectory, here is the complete review.
Crystal Crop Protection — an IFC-backed integrated agri-solutions platform with agrochemicals, hybrid seeds and natural crop protection — received SEBI approval on May 4, 2026 for a ₹600 crore fresh issue plus an OFS of 74 lakh shares by IFC and IFC Emerging Asia Fund. IIFL Capital Services is the lead manager. Here is the complete review.
Showing 12 of 60 articles in “IPO Review”
Hotel Polo Towers — operator of upscale and midscale hotels under the Polo and Max brands across northeast, east and north India — received SEBI approval in May 2026 for a ₹300 crore fresh issue plus an OFS of 71.2 lakh shares. With Northeast India's tourism on a structural up-cycle, here is the complete review.
Horizon Industrial Parks — Blackstone's flagship Indian Grade-A warehousing platform with 60M+ sq ft across 10 cities — received SEBI approval on May 5, 2026 for a ₹2,600 crore pure fresh-issue IPO. Of the proceeds, ₹2,250 Cr will go to debt repayment. JM Financial is the lead manager. Here is the complete review.
Dhoot Transmission — a Bain Capital-backed manufacturer of complex wiring harnesses, electronic sensors and automotive switches for global 2-wheeler and commercial-vehicle OEMs — received SEBI approval on May 5, 2026 for a ~₹2,258 crore ($250M) IPO. Filed via the confidential route in February 2026, the offering combines a fresh issue with an OFS by existing investors. Here is the complete review.
Pride Hotels — India's 6th largest hotel chain by owned inventory in upscale, upper midscale and midscale segments — received SEBI approval on January 23, 2026 for a ~₹1,000 crore IPO comprising ₹260 Cr fresh issue plus OFS of 3.92 crore shares. 34 hotels (7 owned + 27 managed) and a 32-hotel development pipeline. Full review of dates, price band, GMP, financials, strengths, risks and should-you-apply framework.
Hindustan Urvarak & Rasayan (HURL) — the NTPC, Indian Oil and Coal India JV — plans an FY27 IPO worth ₹5,000–6,000 crore via OFS. Complete review of timeline, plants, strengths and risks.
Garuda Aerospace — MS Dhoni-backed Chennai drone manufacturer — pre-filed DRHP with SEBI on April 7, 2026 for a ₹750 Cr fresh issue plus OFS, targeting ~₹1,000 Cr total raise at a ₹4,000-5,000 Cr valuation. Expected December 2026 listing. FY25 revenue ₹118-125 Cr, BEL MoU signed. Full IPO review.
Complete analysis of the upcoming Reliance Jio IPO — expected date, likely price band, valuation estimates, financial snapshot, strengths, risks, GMP guidance, and whether retail investors should apply.
Zepto IPO is India's first quick commerce public listing. Expected ~₹10,000 Cr issue in H2 2026. Complete guide to dates, price band, GMP, strengths, risks and application process.
